Evidence map›Paper›PMID 25544902›Full record

ArticleCase reports in critical care2014

Systemic capillary leak syndrome: is methylene blue the silver bullet?

Michele Umbrello, Marco Gardinali, Davide Ottolina, Giancarlo Zanforlin, Gaetano Iapichino

Open access · goldAbstract read
In one paragraph

Article in Case reports in critical care, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Systemic capillary leak syndrome.Nature reviews. Disease primers · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Chronic idiopathic systemic capillary leak syndrome: a case report.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2019
    Article
  10. Article
  11. Idiopathic systemic capillary leak syndrome (Clarkson disease).The Journal of allergy and clinical immunology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michele UmbrelloUnità Operativa di Anestesia e Rianimazione, Azienda Ospedaliera San Paolo, Polo Universitario, Via A. Di Rudinì 8, 20142 Milano, Italy.
Marco GardinaliUnità Operativa di Medicina IV, Azienda Ospedaliera San Paolo, Polo Universitario, Via A. Di Rudinì 8, 20142 Milano, Italy.
Davide OttolinaUnità Operativa di Anestesia e Rianimazione, Azienda Ospedaliera San Paolo, Polo Universitario, Via A. Di Rudinì 8, 20142 Milano, Italy.
Giancarlo ZanforlinUnità Operativa di Anestesia e Rianimazione, Azienda Ospedaliera San Paolo, Polo Universitario, Via A. Di Rudinì 8, 20142 Milano, Italy.
Gaetano IapichinoUnità Operativa di Anestesia e Rianimazione, Azienda Ospedaliera San Paolo, Polo Universitario, Via A. Di Rudinì 8, 20142 Milano, Italy ; Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Via F. Sforza 35, 20122 Milano, Italy.
Ospedale San Paolo · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. Systemic capillary leak syndrome (SCLS) is a rare disorder characterized by unexplained, recurrent episodes of transient, abrupt increase in endothelial permeability, leading to severe hypotension, generalized edema, and hemoconcentration. Case Report. We report the case of a patient suffering from systemic capillary leak syndrome and present a possible interpretation of the pathophysiology of this condition. Besides the classical triad of hypotension, edema, and hemoconcentration, we recorded increased levels of methemoglobin, an index of NO overproduction. We present a possible interpretation of the pathophysiology of this condition based on the fast and complete reversal of symptoms after methylene blue administration (which opposes NO-induced effects) and speculate that increased NO levels could be implicated in the pathophysiology of the capillary leak phase. Why should an emergency physician be aware of this? The safety of this treatment and its fluid- and cathecolamine-sparing effect deserve consideration and further research.

Identifiers

PMID25544902
PMCPMC4273586
OpenAlexW1983088443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.